Chemo may be given after surgery has been done to remove the cancer. This is called adjuvant treatment. The goal of adjuvant chemo is to kill any areas of cancer that may have been left behind but are ...

The past few decades have witnessed an evolution of nanomedicine from biologically inert entities to more smart systems, aimed at advancing in vivo functionality. However, we should recognize that ...

Pancreatic ductal adenocarcinoma is a highly challenging disease with a 5-year survival rate of less than 5%. 1 Although most patients present with advanced disease, the best outcomes are seen in ...

The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the safety and efficacy of ...

Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...

The FDA approved datopotamab deruxtecan-dlnk (Datroway; Daiichi Sankyo) for the treatment of locally advanced or metastatic ...

Prior authorization varies by plan but often requires patients or their providers to get permission (also called ...

Introduction Duloxetine has previously been reported to be promising in the setting of chemotherapy-induced peripheral neuropathy (CIPN). The aim of this study was to conduct a comprehensive ...

During the early days of research on bone marrow transplants, the procedure was difficult for patients to endure and had a ...

Philadelphia-based Fox Chase Cancer Center has opened a new oncology satellite pharmacy, tripling its capacity to prepare chemotherapy and intravenous medications. The facility, unveiled at a press ...

Background Intravenous iron therapy with ferric derisomaltose (FDI) has been shown to improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency.